A global blueprint on tuberculosis (TB) vaccines that maps out key research and development priorities for the next decade has been published today in a special issue of the journal Tuberculosis.
TB kills around 1.5 million people and infects 9 million others annually. Researchers hope to eliminate the disease by 2050 but, to do so, they say new vaccines will be needed in addition to better therapies and diagnostics.
'Tuberculosis Vaccines: A Strategic Blueprint for Tuberculosis Vaccine Development' builds on conclusions reached at the Second Global Forum on TB Vaccines in Tallinn, Estonia in 2010, which brought together leading experts and stakeholders in TB vaccines.
To read the full, original article click on this link: TB community releases vaccine research blueprint - SciDev.Net
